– Receiving Procedure and Form(s) for: Amino Acids – L-Isoleucine
– Document will include the following Sections; Signatories,
Purpose, Scope, Introduction, Policy, Procedures (Receiving
Inspection, QC Hold/Quarantine, Sampling, Testing and Result
Determination, Acceptance, Rejection and Disposal, Storage) ,
Responsibility, Corrective Action, Review Requirements,
References Documents (Forms for Records), and History.
– Send Material Specification Sheet and Certificate of Analysis for
evaluation, if applicable to email@example.com.
– Send approved company logo and your facility address to be
incorporated on the documents, if applicable, to
– Google Meet – Screen Share for discussion. To be scheduled by our
FSQA Compliance Team, if applicable.
– Program(s), Policy (or Policies), Procedure(s), and Form(s)
purchased require customization, review, and approval for their
intended use. Review, and approval are not included on this service.
– Should you need customization assistance, please schedule a
complimentary discussion via gmeet screen share with our FSQA
Compliance Team by emailing firstname.lastname@example.org.
-Recommendation and guidance given or implied are based on best
practices and the adherence to a regulatory or certification body
requirements and may or may not conform to the requirements or
the intended use or application.
– Consult your inhouse Practitioner, Preventive Control Qualified
Individual (PCQI) or Qualified Individuals (QI) prior to the
implementation of the Program(s), Policy (or Policies), Procedure(s),
– Program(s), Policy (or Policies), Procedure(s), and Form(s) created
requires review and approval by your company’s authorized
personnel and qualified personnel.
– Receiving Procedure in word format: Amino Acids – L-Isoleucine
– Form(s) in word or excel format: Inspection Checklist, Sampling
Form, Receiving Form, QC Hold/Quarantine Form,
Acceptance/Rejection Form, Return/Disposal Form, Storage
– 3 to 5 Business Days upon receipt of completed information
required for inputs.
There are no reviews yet.